Please login to the form below

Not currently logged in
Email:
Password:

Antares CEO Wotton resigns

He will move to Advanced Cell Technology

antares paul wottonAntares Pharma CEO Paul Wotton is to resign his position to take over as CEO at development-stage biotech company Advanced Cell Technology.

Wotton spent nearly six years in charge of New Jersey-based Antares, having previously served as CEO of Topigen Pharmaceutical.

His replacement at Antares is Eamonn Hobbs, a current board member of the company.  He has over 30 years of experience in the pharma and medical device sectors.

Hobbs was most recently president and CEO of Delcath Systems, a pharma and medical device company specialising in cancer treatment.

“We have worked closely with Eamonn over the past five years as board members and share his vision for the future,” said Leonard Jacob, chairman of the board of directors.

2nd July 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...

Infographics